跳至主要内容
临床试验/ISRCTN16584442
ISRCTN16584442
已完成
未知

COgnitive Rehabilitation for Parkinson's Disease Dementia: a pilot trial

Betsi Cadwaladr University Health Board0 个研究点目标入组 45 人2015年4月13日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Parkinson's disease dementia and dementia with Lewy bodies
发起方
Betsi Cadwaladr University Health Board
入组人数
45
状态
已完成
最后更新
7年前

概览

简要总结

注册库
who.int
开始日期
2015年4月13日
结束日期
2017年1月1日
最后更新
7年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • Current inclusion criteria as of 22/06/2015:
  • 1\. Diagnosis of Parkinson's disease (PD) according to the UK PD Brain Bank Diagnostic Criteria and a diagnosis of PD dementia according to the Movement Disorder Society consensus criteria or
  • 2\. Diagnosis of Dementia with Lewy Bodies (DLB) according to the DLB Consortium consensus criteria.
  • 3\. Clinical diagnosis of mild to moderate dementia with an ACE\-III score of \=82
  • 4\. Participants will preferably have a carer or family member who is willing to participate but this is not an absolute requirement
  • 5\. Participants should be on stable medication for their Parkinsonism and cognition (including acetylcholinesterase inhibitors) for four weeks prior to commencement with no changes planned for the duration of the intervention. Any unplanned changes in medication during the intervention will be documented
  • Previous inclusion criteria:
  • 1\. Diagnosis of Parkinson's disease (PD) according to the UK PD Brain Bank Diagnostic Criteria and a diagnosis of PD dementia according to the Movement Disorder Society consensus criteria or;
  • 2\. Diagnosis of Dementia with Lewy Bodies (DLB) according to the DLB Consortium consensus criteria.
  • 3\. Clinical diagnosis of mild to moderate dementia with an ACE\-III score of \<80

排除标准

  • 1\. Lack of stability of Parkinson's disease (PD) medications, cognitive enhancers or psychotropic medication or substantial additions to medication in the four weeks before the trial or planned changes during the period of the trial
  • 2\. Other major psychiatric disorder not related to PD
  • 3\. Major depression
  • 4\. Other significant neurological disease

结局指标

主要结局

未指定

相似试验